diagnostic role of n-acetyl-β-d-glucosaminidase as an early marker of kidney damage
Clicks: 226
ID: 163214
2016
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
30.0
/100
226 views
23 readers
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #26 of 39 articles by views in oncology letters
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
In many diseases of the kidneys, N-acetyl-β-D-glucosaminidase (NAG) in the urine is excreted in large quantities. A significant increase in NAG activity is observed at the primary and secondary kidney damage, heavy metal poisoning, kidney transplantation, kidney tumor, hypertension, preeclampsia in pregnant women, diabetic nephropathy, polycystic kidneys, glomerulonephritis. Commercial kits have been developed to measure the activity of NAG c using a colorimetric (biochemical) and enzyme-linked immunosorbent (ELISA) methods of research.
| Reference Key |
melnyk2016pokidiagnostic
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;O.O. Melnyk |
| Journal | oncology letters |
| Year | 2016 |
| DOI |
10.22141/2307-1257.4.18.2016.84327
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.